author-photo

Thomas A. Baillie

University of Washington
Merck & Co.
United States Military Academy

213

Papers

12828

Citations

Citation Trend

Filter By

Papers (213) Sort By

Journal Conference Others

Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV-50717) Compared With Tetrabenazine in Healthy Volunteers.

2020 Clinical and Translational Science
Show All
- Source
- Cite
- Save
Citations (6)
Drug–protein adducts: past, present, and future

2020 Medicinal Chemistry Research
- Thomas A. Baillie
Show All
- Source
- Cite
- Save
Citations (6)
Approaches to Mitigate the Risk of Serious Adverse Reactions in Covalent Drug Design.

2020 Expert Opinion on Drug Discovery
- Thomas A. Baillie
Show All
- Source
- Cite
- Save
Citations (6)
Targeted covalent inhibitors for drug design

2019 Drug Metabolism and Pharmacokinetics
- Thomas A. Baillie
Show All
- Source
- Cite
- Save
Citations (0)
Managing Metabolic Activation Issues in Drug Discovery

2019
Show All
- Source
- Cite
- Save
Citations (1)
An open-label, two-period study designed to evaluate and compare the mass balance recovery and metabolite profile of 14 c deutetrabenazine and 14 c-tetrabenazine in healthy male subjects

2018 Drug Metabolism and Pharmacokinetics
Show All
- Source
- Cite
- Save
Citations (0)
Safety Assessment of Acyl Glucuronides - A Simplified Paradigm

2018 Drug Metabolism and Disposition
Show All
- Source
- Cite
- Save
Citations (19)
Targeted Covalent Inhibitors for Drug Design

2016 ChemInform
- Thomas A. Baillie
Show All
- Source
- Cite
- Save
Citations (1)
Biotransformation and bioactivation reactions – 2015 literature highlights

2016 Drug Metabolism Reviews
Show All
- Source
- Cite
- Save
Citations (8)
Zielgerichtete kovalente Inhibitoren für das Wirkstoffdesign

2016 Angewandte Chemie
- Thomas A. Baillie
Show All
- Source
- Cite
- Save
Citations (27)